Cleveland BioLabs
CBLI
#9804
Rank
โ‚ฌ41.96 M
Marketcap
2,71ย โ‚ฌ
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Revenue for Cleveland BioLabs (CBLI)

Revenue in 2020 (TTM): โ‚ฌ0.56 Million

According to Cleveland BioLabs 's latest financial reports the company's current revenue is โ‚ฌ0.54 Million. In 2019 the company made a revenue of โ‚ฌ0.95 Million a decrease over the revenue in the year 2018 that were of โ‚ฌ0.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cleveland BioLabs from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ0.56 M-40.74%
2019โ‚ฌ0.95 M-2.18%
2018โ‚ฌ0.97 M-41.58%
2017โ‚ฌ1.66 M-44.62%
2016โ‚ฌ3 M29.92%
2015โ‚ฌ2.31 M-26.84%
2014โ‚ฌ3.16 M-56.39%
2013โ‚ฌ7.25 M137.71%
2012โ‚ฌ3.05 M-59.38%
2011โ‚ฌ7.51 M-42.67%
2010โ‚ฌ13.11 M6.87%
2009โ‚ฌ12.27 M204.87%
2008โ‚ฌ4.02 M133.12%
2007โ‚ฌ1.72 M18.17%
2006โ‚ฌ1.46 M50%
2005โ‚ฌ0.97 M78.97%
2004โ‚ฌ0.54 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-64.23%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.54 B 101,518.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.76 B 5,692,937.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.21 B 8,921,750.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
โ‚ฌ41.08 B 7,602,117.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.64 B 7,521,571.71%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ36.22 B 6,702,964.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.82 B 9,404,118.14%๐Ÿ‡บ๐Ÿ‡ธ USA